Literature DB >> 22687462

Involvement and interplay of Parkin, PINK1, and DJ1 in neurodegenerative and neuroinflammatory disorders.

Micha M M Wilhelmus1, Philip G Nijland, Benjamin Drukarch, Helga E de Vries, Jack van Horssen.   

Abstract

The involvement of parkin, PINK1, and DJ1 in mitochondrial dysfunction, oxidative injury, and impaired functioning of the ubiquitin-proteasome system (UPS) has been intensively investigated in light of Parkinson's disease (PD) pathogenesis. However, these pathological mechanisms are not restricted to PD, but are common denominators of various neurodegenerative and neuroinflammatory disorders. It is therefore conceivable that parkin, PINK1, and DJ1 are also linked to the pathogenesis of other neurological diseases, including Alzheimer's disease (AD) and multiple sclerosis (MS). The importance of these proteins in mechanisms underlying neurodegeneration is reflected by the neuroprotective properties of parkin, DJ1, and PINK1 in counteracting oxidative stress and improvement of mitochondrial and UPS functioning. This review provides a concise overview on the cellular functions of the E3 ubiquitin ligase parkin, the mitochondrial kinase PINK1, and the cytoprotective protein DJ1 and their involvement and interplay in processes underlying neurodegeneration in common neurological disorders.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22687462     DOI: 10.1016/j.freeradbiomed.2012.05.040

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  22 in total

1.  The effects of pdr1, djr1.1 and pink1 loss in manganese-induced toxicity and the role of α-synuclein in C. elegans.

Authors:  Julia Bornhorst; Sudipta Chakraborty; Sören Meyer; Hanna Lohren; Sigrid Grosse Brinkhaus; Adam L Knight; Kim A Caldwell; Guy A Caldwell; Uwe Karst; Tanja Schwerdtle; Aaron Bowman; Michael Aschner
Journal:  Metallomics       Date:  2014-01-22       Impact factor: 4.526

2.  Modulation of ARTS and XIAP by Parkin Is Associated with Carnosic Acid Protects SH-SY5Y Cells against 6-Hydroxydopamine-Induced Apoptosis.

Authors:  Ru-Huei Fu; Li-Chun Huang; Chia-Yuan Lin; Chia-Wen Tsai
Journal:  Mol Neurobiol       Date:  2017-02-21       Impact factor: 5.590

3.  DJ1 represses glycolysis and cell proliferation by transcriptionally up-regulating Pink1.

Authors:  Raquel Requejo-Aguilar; Irene Lopez-Fabuel; Daniel Jimenez-Blasco; Emilio Fernandez; Angeles Almeida; Juan P Bolaños
Journal:  Biochem J       Date:  2015-04-15       Impact factor: 3.857

4.  Identification of Altered Blood MicroRNAs and Plasma Proteins in a Rat Model of Parkinson's Disease.

Authors:  Sanjeev Kumar Yadav; Anuj Pandey; Sana Sarkar; Smriti Singh Yadav; Devendra Parmar; Sanjay Yadav
Journal:  Mol Neurobiol       Date:  2022-01-13       Impact factor: 5.590

Review 5.  Parkinson's disease and enhanced inflammatory response.

Authors:  Iva Stojkovska; Brandon M Wagner; Brad E Morrison
Journal:  Exp Biol Med (Maywood)       Date:  2015-03-13

Review 6.  Mitochondrial control of cell bioenergetics in Parkinson's disease.

Authors:  Raquel Requejo-Aguilar; Juan P Bolaños
Journal:  Free Radic Biol Med       Date:  2016-04-16       Impact factor: 7.376

Review 7.  Changes in expression levels of oxidative stress-related genes in mouse epididymides by neonatal exposure to low-dose decabromodiphenyl ether.

Authors:  Makoto Nakamoto; Hidenobu Miyaso; Masatoshi Komiyama; Yoshiharu Matsuno; Chisato Mori
Journal:  Reprod Med Biol       Date:  2013-12-31

8.  Epigenome-wide association study for Parkinson's disease.

Authors:  Kerry Moore; Amy Jayne McKnight; David Craig; Francis O'Neill
Journal:  Neuromolecular Med       Date:  2014-10-11       Impact factor: 3.843

Review 9.  SUMO and Parkinson's disease.

Authors:  Katrin Eckermann
Journal:  Neuromolecular Med       Date:  2013-08-25       Impact factor: 3.843

10.  Neurotransmitter CART as a New Therapeutic Candidate for Parkinson's Disease.

Authors:  Peizhong Mao; Charles K Meshul; Philippe Thuillier; P Hemachandra Reddy
Journal:  Pharmaceuticals (Basel)       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.